Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Obesity

This Little-Known Stock Just Doubled on Weight-Loss Drug News. Analysts Think It Has 400% Upside Potential From Here.

This weight-loss underdog doubled in a single day last week and could deliver even bigger rewards.

Barchart

Why isn’t Ozempic on Australia’s Pharmaceutical Benefits Scheme for weight loss? And should it be?

The drug is subsidised for treatment of type 2 diabetes but experts say it could help reduce other health problems associated with severe obesity

The Guardian - AU

Semaglutide: a "wonder drug" with risks

New research is finding semaglutide, a diabetes and obesity drug, has a lot to teach about how the body works

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk

Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.

Investors Business Daily

Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms

Novo Nordisk stock surged Friday after the obesity kingpin reported strong results for its next-generation weight-loss drug, amycretin.

Investors Business Daily

In Texas’ Rio Grande Valley, a push for residents to lose weight and curb diabetes

In Brownsville, the city and local hospital have helped residents lose more than 23,000 pounds since 2008.

The Texas Tribune

Why is obesity linked to irregular heart rhythms? Researchers found 1 potential mechanism

Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person’s risk of stroke, heart failure and even premature death.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

People on Ozempic may have fewer heart attacks, strokes and addictions – but more nausea, vomiting and stomach pain

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.

The Conversation

Every Drink Elevates Your Cancer Risk. So, How Much Alcohol You Can Safely Drink?

Alcohol is the third-most preventable cause of cancer in the U.S, putting it just behind tobacco and obesity.

Inverse

After call to overhaul diagnosis of obesity, how can you tell if your weight is a problem?

Report by Lancet Commission says BMI should be used as ‘screening tool’ rather than determining factor

The Guardian - UK

Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of unknowns.

Investors Business Daily

Friday briefing: What new research about the limits of the body mass index might tell us about obesity

In today’s newsletter: An international commission has called for a ‘radical overhaul’ of the way obesity is diagnosed, raising concerns about the limitations of body mass index (BMI) as a diagnostic tool

The Guardian - UK

Forget BMI – there’s a 2,000 year-old technique for measuring body fat that’s more useful

It’s the start of another year and the body mass index (BMI) is being criticised again. This time a Lancet-commissioned group of experts is denouncing it as a diagnostic tool for obesity. They say that doctors should look at the overall health of a patient when diagnosing obesity, not just…

The Conversation

Forcing children to finish meals could be fuelling obesity crisis

Children need portion sizes that reflect their body size

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Is Obesity A Disease? Sometimes But Not Always, Experts Decide

Do people with obesity have an illness? When obesity affects the functions of people's organs, it should be considered a distinct illness called "clinical obesity," the commission said.

Evening Standard

Large portions and forcing children to finish meals ‘could be fuelling obesity’

Almost a third of parents say they need more guidance on deciding the appropriate portion sizes for their children.

The Independent UK

Experts row back on ‘flawed’ BMI as millions wrongly diagnosed with obesity

Roughly 20% of people who used to be classified as obese will no longer meet the definition

The Conversation

How we diagnose and define obesity is set to change – here’s why, and what it means for treatment

Obesity is linked to many common diseases, such as type 2 diabetes, heart disease, fatty liver disease and knee osteoarthritis.

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

58 medical experts propose to overhaul BMI usage in obesity diagnosis and treatment

Over one billion people in the world are estimated to have obesity. Some experts believe its treatment and diagnosis need a radical change.

The Guardian - UK

Reframing obesity may end the diagnosis debate, but the health challenges remain

Assessment of the condition could face overhaul, but governments, companies and communities still have work to do

The Guardian - UK

Call to overhaul obesity diagnoses amid fears of over-reliance on BMI

Lancet commission’s report calls for global shake-up and suggests looking at measures such as waist-to-height ratios and ill-health symptoms

The Independent UK

People ‘being misdiagnosed’ on obesity, say experts

Researchers have said there needs to be a more ‘nuanced’ way to measure obesity.

The Conversation

Children with traumatic experiences have a higher risk of obesity – but this can be turned around

Children with traumatic experiences in their early lives have a higher risk of obesity. But as our new research shows, this risk can be reduced through positive experiences.

The Conversation

Bowel cancer is on the rise in under-50s – here’s what might explain the trend

Almost 2 million people are diagnosed with bowel cancer each year. Also known as colorectal cancer, it’s the third most common cancer worldwide.

Salon

Weight loss: The business of shame

Fat-shaming drove people to Ozempic. Now its competitors are using shame to try to lure them away

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.